Cytokinetics, Incorporated · NASDAQ:CYTK

Blum Robert I sold 7,500 Cytokinetics, Incorporated shares (Form 4)

Traded Jul 13, 2026 · Filed Jul 14, 2026

On Jul 13, 2026, Blum Robert I (Director, President & CEO) sold 7,500 Cytokinetics, Incorporated shares at US$82.02 for US$615K under a trading plan, leaving 377,820 shares. Filed Jul 14, 2026 (Form 4).

Sold
7,500 shares
Price
US$82.02
Value
US$615K
Holding after
377,820 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 13, 2026Common StockSale10US$82.02377,820Direct
Jul 13, 2026Common StockOption exercise7,490US$10.60385,310Direct
Jul 13, 2026Common StockSale7,490US$82.02377,820Direct

Source

View original at SEC

Related